Formula 22158 14 mg Capsule is a Health Canada–registered human drug (DIN 00191531) held by Therapeutic Foods Co., containing Potassium Bicarbonate. Health Canada lists its status as Cancelled Post Market (status date 07 Aug 1997). Nexara Health has matched 10 registrations of Potassium Bicarbonate across 1 other regulated market.
Health Canada registration
| DIN | 00191531 |
|---|---|
| Brand name | Formula 22158 |
| Active ingredient | Potassium Bicarbonate |
| Strength | 14 mg |
| Dosage form | Capsule |
| Route | Oral |
| Company | Therapeutic Foods Co. |
| Status | Cancelled Post Market — 07 Aug 1997 |
| Class | Human |
| ATC | |
| AHFS | 88:29.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Potassium Bicarbonate registered in other markets
10 registrations of the same molecule in 1 national registry outside Canada (first 8 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Effer-K 10 mEq Cherry Vanilla | Nomax Inc. | Tablet, Effervescent | listed | FDA NDC | |
| United States | Effer-K 10 mEq Unflavored | Nomax Inc. | Tablet, Effervescent | listed | FDA NDC | |
| United States | Effer-K 20 mEq Orange Cream | Nomax Inc. | Tablet, Effervescent | listed | FDA NDC | |
| United States | Effer-K 20 mEq Unflavored | Nomax Inc. | Tablet, Effervescent | listed | FDA NDC | |
| United States | Effer-K Cherry Berry | Nomax Inc. | Tablet, Effervescent | listed | FDA NDC | |
| United States | Effer-K Lemon Citrus | Nomax Inc. | Tablet, Effervescent | listed | FDA NDC | |
| United States | Effer-K Orange | Nomax Inc. | Tablet, Effervescent | listed | FDA NDC | |
| United States | Effer-K Unflavored | Nomax Inc. | Tablet, Effervescent | listed | FDA NDC |
See every manufacturer of Potassium Bicarbonate worldwide →
Marketed Canadian products with the same active ingredient
| DIN | Product | Company | Strength | Form |
|---|---|---|---|---|
| 02413760 | Formula 3 | The Tetra Corporation | 1 % | Solution |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Formula 22158 (DIN 00191531) marketed in Canada?
No. Health Canada lists DIN 00191531 as Cancelled Post Market as of 07 Aug 1997.
Who holds the Canadian licence for this product?
Therapeutic Foods Co. is the company of record in the Health Canada Drug Product Database.
Is Potassium Bicarbonate registered outside Canada?
Yes — Nexara Health has matched 10 registrations in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00191531, status date 1997-08-07; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00191531, status date 1997-08-07; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 00191531, status date 1997-08-07; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.